Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HLF | Common Stock | Award | $0 | +346K | +125.8% | $0.00 | 621K | Dec 22, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HLF | Stock Appreciation Rights | Award | $0 | +784K | $0.00 | 784K | Dec 22, 2022 | Common Stock | 784K | $14.45 | Direct | F2 |
Id | Content |
---|---|
F1 | Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 50% on December 22, 2023, and December 22, 2024, subject to certain terms and conditions of his continuing service as CEO and/or member of the Board. |
F2 | On December 22, 2022, the reporting person was granted 783,699 SARs. These SARs will vest 100% on December 22, 2024, subject to certain terms and conditions of his continuing service as CEO and/or member of the Board. |